Abeona therapeutics appoints head of research & clinical development

New york and cleveland, may 25, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced the appointment of vishwas seshadri, ph.d., m.b.a., as senior vice president, head of research & clinical development, effective june 1, 2021. dr. seshadri joins the company from celgene corporation, now a subsidiary of bristol-myers squibb company (bms), and brings more than 20 years of experience including in academia and various senior and executive leadership roles in the life sciences industry overseeing product development, regulatory submissions, and commercialization for novel therapies including personalized, autologous cell therapies.
ABEO Ratings Summary
ABEO Quant Ranking